Publications
Dual-energy computed tomography for improved visualization of internal jugular chain neck lymph node metastasis and nodal necrosis in head and neck squamous cell carcinoma
Baba, A,
Kurokawa, R,
Kurokawa, M,
Rivera-de Choudens, R,
Srinivasan, A,
Jpn J Radiol, 2023 Jun; DOI:10.1007/s11604-023-01460-9 P-629 Dietary and/or physical activity interventions in women with overweight or obesity prior to fertility treatment – an individual participant data meta-analysis (Venus-IPD)
Wang, Z,
Evans-Hoeker, E,
Cantineau, A,
Legro, R,
Thurin-Kjellberg, A,
Bergh, C,
Laven, J,
Sim, K,
Espinós, J,
Moholdt, T,
Rothberg, A,
Hoek, A,
Mol, B,
Groen, H,
Wang, R,
Human Reproduction, 2023 Jun; DOI:10.1093/humrep/dead093.957 Precise Conformational Control Yielding Highly Potent and Exceptionally Selective BRD4 Degraders with Strong Antitumor Activity
Hu, J,
Hu, B,
Xu, F,
Wang, M,
Qin, C,
McEachern, D,
Stuckey, J,
Wang, S,
J Med Chem, 2023 Jun; DOI:10.1021/acs.jmedchem.3c00520 Enhanced mitochondrial fission inhibits triple-negative breast cancer cell migration through an ROS-dependent mechanism
Humphries, BA,
Zhang, A,
Buschhaus, JM,
Bevoor, A,
Farfel, A,
Rajendran, S,
Cutter, AC,
Luker, GD,
iScience, 2023 Jun; DOI:10.1016/j.isci.2023.106788 H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Pediatric High-Grade Gliomas.
Garcia-Fabiani, MB,
Haase, S,
Banerjee, K,
McClellan, B,
Zhu, Z,
Mujeeb, A,
Li, Y,
Yu, J,
Kadiyala, P,
Taher, A,
Núñez, FJ,
Alghamri, MS,
Comba, A,
Mendez, FM,
Nicola Candia, AJ,
Salazar, B,
Koschmann, C,
Nunez, FM,
Edwards, M,
Qin, T,
Sartor, MA,
Lowenstein, PR,
Castro, MG,
2023 Jun; DOI:10.1101/2023.06.13.544658 DIPG-26. CLINICAL AND GENOMIC ANALYSIS OF H3K27M-DMG LONG-TERM SURVIVORS REVEALS ENRICHMENT IN MAPK PATHWAY ALTERATIONS
Roberts, H,
Picca, A,
Sanson, M,
Schüller, U,
Picart, T,
Ducray, F,
Green, A,
Nakano, Y,
Sturm, D,
Abdullaev, Z,
Aldape, K,
Waszak, S,
Venneti, S,
Pratt, D,
Koschmann, C,
Neuro-Oncology, 2023 Jun; DOI:10.1093/neuonc/noad073.073 TRLS-10. ROVER: A PHASE 1/2 STUDY OF AVAPRITINIB IN PEDIATRIC PATIENTS WITH SOLID TUMORS DEPENDENT ON KIT OR PDGFRA SIGNALING
Koschmann, C,
Hoffman, LM,
Kramm, CM,
Plant-Fox, A,
Abdelbaki, MS,
Bui, A,
Casanova, M,
Morgenstern, DA,
Swamy, P,
Shi, H,
Hong, J,
Rinne, ML,
Chi, SN,
Neuro-Oncology, 2023 Jun; DOI:10.1093/neuonc/noad073.313 HGG-19. CLINICAL RESPONSE TO THE PDGFRA/KIT INHIBITOR AVAPRITINIB IN PEDIATRIC AND YOUNG ADULT HIGH-GRADE GLIOMA PATIENTS WITH H3K27M OR PDGFRA GENOMIC ALTERATIONS
Trissal, M,
Mayr, L,
Schwark, K,
LaBelle, J,
Kong, S,
Furtner, J,
Weiler-Wichtl, L,
Supko, J,
Rozowsky, J,
Hack, O,
Groves, A,
Marques, J,
Leiss, U,
Rosenmayr, V,
Dubois, F,
Greenwald, NF,
Madlener, S,
Guntner, AS,
Pálová, H,
Stepien, N,
Lötsch-Gojo, D,
Dorfer, C,
Dieckmann, K,
Peyrl, A,
Azizi, AA,
Baumgartner, A,
Slabý, O,
Pokorná, P,
Bandopadhayay, P,
Beroukhim, RBRDHE,
Ligon, KL,
Kramm, CM,
Bronsema, A,
Bailey, S,
Stucklin, AG,
Mueller, SM,
Jones, DTW,
Jäger, N,
Mullauer, L,
Haberler, C,
Kumar-Sinha, C,
Chinnaiyan, A,
Mody, R,
Štěrba, JŠSJFC,
Skrypek, M,
Martinez, N,
Bowers, DC,
Koschmann, CK,
Gojo, J,
Filbin, M,
Neuro-Oncology, 2023 Jun; DOI:10.1093/neuonc/noad073.168 CNSC-01. GABAERGIC NEURON-TO-GLIOMA SYNAPSES IN DIFFUSE MIDLINE GLIOMAS
Barron, T,
Yalçın, B,
Mochizuki, A,
Cantor, E,
Shamardani, K,
Tlais, D,
Franson, A,
Lyons, S,
Mehta, V,
Jahan, SM,
Taylor, K,
Keough, M,
Xu, H,
Su, M,
Quezada, M,
Woo, P,
Fisher, P,
Campen, C,
Partap, S,
Koschmann, C,
Monje, M,
Neuro-Oncology, 2023 Jun; DOI:10.1093/neuonc/noad073.044 Abstract A027: Identification and characterization of PLUTO-201, a novel lncRNA associated with prostate cancer metastasis
Li, H,
Younger, N,
Shin, HJ,
Malik, B,
Zhao, SG,
Pitchiaya, S,
Calvert, M,
Zhang, M,
Chang, L,
Chesner, L,
Hua, J,
Li, K,
Kothari, V,
Egusa, E,
Chou, J,
Das, R,
Burlingame, A,
Chinnaiyan, AM,
Li, H,
Feng, FY,
Cancer Research, 2023 Jun; DOI:10.1158/1538-7445.prca2023-a027 Abstract A067: Cellular cartography reveals transcriptional specificity and spatial organization of diverse luminal epithelial cells in the murine prostate
Cho, H,
Zhang, Y,
Tien, J,
Luo, J,
Wilke, JE,
Dhanasekaran, SM,
Mannan, R,
Wang, L,
Su, F,
Wang, R,
Keller, ET,
Cao, X,
Pitchaya, S,
Chinnaiyan, AM,
Cancer Research, 2023 Jun; DOI:10.1158/1538-7445.prca2023-a067 Abstract A040: Multi-site sequencing of lethal prostate cancer reveals metastatic dissemination by independent and early-branching clones
Hosseini, N,
Reichert, Z,
Mehra, R,
Chinnaiyan, A,
Cieslik, M,
Cancer Research, 2023 Jun; DOI:10.1158/1538-7445.prca2023-a040 Abstract A056: AR/FOXA1-mediated active gene repression as a mechanism of prostate carcinogenesis
Eyunni, S,
Parolia, A,
Young, E,
George, J,
Jaber, M,
Xiao, L,
Su, F,
Wang, R,
Cao, X,
Chinnaiyan, A,
Cancer Research, 2023 Jun; DOI:10.1158/1538-7445.prca2023-a056 Abstract A055: NSD2 is a requisite and targetable subunit of the AR/FOXA1 neo -enhanceosome complex in prostate cancer cells
Parolia, A,
Verma, BK,
Eyunni, S,
Aras, S,
Carson, SE,
Young, E,
Das, CK,
George, JM,
Rasool, RU,
Gajjala, P,
Alhusayan, M,
Mitchell-Velasquez, E,
Xiao, L,
Luo, J,
Jaber, M,
Cao, X,
Su, F,
Wang, R,
Liu, L,
Wang, Z,
Ding, K,
Chinnaiyan, AM,
Asangani, I,
Cancer Research, 2023 Jun; DOI:10.1158/1538-7445.prca2023-a055 High-grade B-cell lymphoma with concurrent MYC rearrangement and 11q aberrations: clinicopathologic, cytogenetic, and molecular characterization of 4 cases
Shestakova, A,
Shao, L,
Smith, LB,
Ryan, R,
Bedell, V,
Murata-Collins, J,
Zhang, W,
Perry, AM,
Song, JY,
Hum Pathol, 2023 Jun; DOI:10.1016/j.humpath.2023.03.013 Role of HLA-DRB4 as a biomarker for endocrine toxicity and survival outcomes after immunotherapy in metastatic non-small cell lung cancer.
Jiang, C,
Ravishankar, S,
Zhao, L,
Green, M,
Towlerton, A,
Scott, A,
Raghavan, M,
Cusick, M,
Warren, EH,
Ramnath, N,
Journal of Clinical Oncology, 2023 Jun; DOI:10.1200/jco.2023.41.16_suppl.e21005 Biomarkers of response to sacituzumab govitecan (SG) and efficacy after treatment with enfortumab vedotin (EV) in advanced urothelial carcinoma (aUC): Analysis of the UNITE study.
Jindal, T,
Jiang, C,
Alhalabi, O,
Bakaloudi, DR,
Talukder, R,
Davidsohn, M,
Nizam, A,
Taylor, AK,
Nguyen, CB,
Kilari, D,
Pywell, C,
Davis, NB,
Emamekhoo, H,
Sonpavde, GP,
Gupta, S,
Bellmunt, J,
Grivas, P,
Campbell, MT,
Alva, AS,
Koshkin, VS,
Journal of Clinical Oncology, 2023 Jun; DOI:10.1200/jco.2023.41.16_suppl.4572 SWOG S1011: A phase III surgical trial to evaluate the benefit of a standard versus an extended lymphadenectomy performed at time of radical cystectomy for muscle invasive urothelial cancer.
Lerner, SP,
Tangen, C,
Svatek, RS,
Daneshmand, S,
Pohar, KS,
Skinner, EC,
Schuckman, AK,
Sagalowsky, AI,
Smith, ND,
Kamat, AM,
Kassouf, W,
Plets, M,
Bangs, R,
Koppie, TM,
Alva, AS,
La Rosa, FG,
Pal, SK,
Kibel, AS,
Canter, D,
Thompson, IM,
Journal of Clinical Oncology, 2023 Jun; DOI:10.1200/jco.2023.41.16_suppl.4508 Independent biomarkers predictive of outcomes with enfortumab vedotin (EV) in patients (pts) with advanced urothelial carcinoma (aUC): Analysis of the UNITE study.
Jindal, T,
Zhang, L,
Jiang, C,
Kilari, D,
Alhalabi, O,
Nizam, A,
Basu, A,
Bilen, MA,
Zakharia, Y,
Milowsky, MI,
Shah, S,
Hoimes, CJ,
Davis, NB,
Gupta, S,
Emamekhoo, H,
Grivas, P,
Bellmunt, J,
Campbell, MT,
Alva, AS,
Koshkin, VS,
Journal of Clinical Oncology, 2023 Jun; DOI:10.1200/jco.2023.41.16_suppl.4573 Colorectal cancer screening with blood-based tests: Estimated impact of a 1-, 2-, or 3-year screening interval compared with annual FIT and triennial mt-sDNA strategies.
Fendrick, AM,
Kisiel, JB,
Ebner, DW,
Ozbay, AB,
Vahdat, V,
Estes, C,
Limburg, PJ,
Journal of Clinical Oncology, 2023 Jun; DOI:10.1200/jco.2023.41.16_suppl.10580 Correlation of unobserved incidence of cancer in earlier stages with the observed incidence.
Chhatwal, J,
ElHabr, A,
Tyson, C,
Merdan, S,
Cao, X,
Raoof, S,
Ozbay, AB,
Fendrick, AM,
Limburg, PJ,
Beer, TM,
Deshmukh, A,
Journal of Clinical Oncology, 2023 Jun; DOI:10.1200/jco.2023.41.16_suppl.10634 Genetic testing outcomes and pathogenic germline mutation prevalence in renal cell carcinoma.
Nguyen, CB,
Knaus, C,
Accardo, M-L,
Koeppe, E,
Alva, AS,
Else, T,
Journal of Clinical Oncology, 2023 Jun; DOI:10.1200/jco.2023.41.16_suppl.10601 Estimated life-years gained and resultant cost savings from follow-up colonoscopy after a positive multi-target stool DNA (mt-sDNA) test for colorectal cancer screening in commercially insured and Medicare populations.
Fendrick, AM,
Kisiel, JB,
Ebner, DW,
Vahdat, V,
Ozbay, AB,
Estes, C,
Limburg, PJ,
Journal of Clinical Oncology, 2023 Jun; DOI:10.1200/jco.2023.41.16_suppl.6642 Outcomes with immune checkpoint inhibitors (ICI) in patients (pts) with MTAP alterations (alt) in advanced urothelial carcinoma (aUC).
Talukder, R,
Bakaloudi, DR,
Lin, GI,
Enright, T,
Leary, JB,
Makrakis, D,
Tripathi, N,
Agarwal, N,
Jindal, T,
Koshkin, VS,
Brown, JR,
Johnson, J,
Zakharia, Y,
Park, JJ,
Alva, AS,
Morales Barrera, R,
Drakaki, A,
Barata, PC,
Khaki, AR,
Grivas, P,
Journal of Clinical Oncology, 2023 Jun; DOI:10.1200/jco.2023.41.16_suppl.4574 Venous thromboembolism prophylaxis during neoadjuvant chemotherapy for patients with ovarian cancer.
McLaughlin, HD,
Straubhar, AM,
Rolston, A,
McCool, K,
Brackmann, M,
Siedel, JH,
McLean, K,
Reynolds, RK,
Uppal, S,
Journal of Clinical Oncology, 2023 Jun; DOI:10.1200/jco.2023.41.16_suppl.5552 